Literature DB >> 33875486

Alcohol Abstinence and the Risk of Atrial Fibrillation in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: A Nationwide Population-Based Study.

You-Jung Choi1, Kyung-Do Han2, Eue-Keun Choi3,4, Jin-Hyeung Jung5, So-Ryoung Lee1, Seil Oh1,4, Gregory Y H Lip4,6,7.   

Abstract

OBJECTIVE: To investigate the effects of alcohol abstinence on prevention of new-onset atrial fibrillation (AF) in patients with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS: A total of 1,112,682 patients newly diagnosed with T2DM between 2011 and 2014 were identified from the Korean National Health Insurance Service database. After excluding those with a history of AF, 175,100 patients were included. The primary outcome was new-onset AF.
RESULTS: During a mean follow-up of 4.0 years, AF occurred in 4,174 patients. Those with heavy alcohol consumption (alcohol intake ≥40 g/day) before T2DM diagnosis had a higher risk of AF (adjusted hazard ratio [aHR] 1.22; 95% CI 1.06-1.41) compared with patients with no alcohol consumption. After T2DM diagnosis, those with moderate to heavy alcohol consumption (alcohol intake ≥20 g/day) who abstained from alcohol had a lower risk of AF (aHR 0.81; 95% CI 0.68-0.97) compared with constant drinkers. Alcohol abstinence showed consistent trends toward lower incident AF in all subgroups and was statistically significant in men (aHR 0.80; 95% CI 0.67-0.96), those aged >65 years (aHR 0.69; 95% CI 0.52-0.91), those with CHA2DS2-VASc score <3 points (aHR 0.71; 95% CI 0.59-0.86), noninsulin users (aHR 0.77; 95% CI 0.63-0.94), and those with BMI <25 kg/m2 (aHR 0.68; 95% CI 0.53-0.88).
CONCLUSIONS: In patients with newly diagnosed T2DM, alcohol abstinence was associated with a low risk of AF development. Lifestyle modifications, such as alcohol abstinence, in patients newly diagnosed with T2DM should be recommended to reduce the risk of AF.
© 2021 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2021        PMID: 33875486      PMCID: PMC8247489          DOI: 10.2337/dc20-2607

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   17.152


  5 in total

1.  2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.

Authors:  Tze-Fan Chao; Boyoung Joung; Yoshihide Takahashi; Toon Wei Lim; Eue-Keun Choi; Yi-Hsin Chan; Yutao Guo; Charn Sriratanasathavorn; Seil Oh; Ken Okumura; Gregory Y H Lip
Journal:  Thromb Haemost       Date:  2021-11-13       Impact factor: 5.249

Review 2.  Alcohol Consumption and the Risk of Incident Atrial Fibrillation: A Meta-Analysis.

Authors:  Georgios Giannopoulos; Ioannis Anagnostopoulos; Maria Kousta; Stavros Vergopoulos; Spyridon Deftereos; Vassilios Vassilikos
Journal:  Diagnostics (Basel)       Date:  2022-02-13

3.  Combined Effects of Chronic Kidney Disease and Nonalcoholic Fatty Liver Disease on the Risk of Cardiovascular Disease in Patients with Diabetes.

Authors:  Goh-Eun Chung; Kyungdo Han; Kyu-Na Lee; Eun-Ju Cho; Jung-Ho Bae; Sun-Young Yang; Su-Jong Yu; Seung-Ho Choi; Jeong-Yoon Yim; Nam-Ju Heo
Journal:  Biomedicines       Date:  2022-05-26

4.  Habitual Alcohol Intake and Risk of Atrial Fibrillation in Young Adults in Korea.

Authors:  Minju Han; So-Ryoung Lee; Eue-Keun Choi; JungMin Choi; Jaewook Chung; Sang-Hyeon Park; HuiJin Lee; Hyo-Jeong Ahn; Soonil Kwon; Seung-Woo Lee; Kyung-Do Han; Seil Oh; Gregory Y H Lip
Journal:  JAMA Netw Open       Date:  2022-09-01

5.  The Change in Metabolic Syndrome Status and the Risk of Nonviral Liver Cirrhosis.

Authors:  Goh-Eun Chung; Young Chang; Yuri Cho; Eun-Ju Cho; Jeong-Ju Yoo; Sang-Hyun Park; Kyungdo Han; Dong-Wook Shin; Su-Jong Yu; Yoon-Jun Kim; Jung-Hwan Yoon
Journal:  Biomedicines       Date:  2021-12-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.